|
| We had a fantastic time at this year’s SOT live meeting, reuniting with all our colleagues in the area of in vitro toxicology. Together with guest speakers from Takasago and Sonova, we presented new GARD® data on agrochemical formulations, fragrance materials, medical devices and metals. We also discussed how in vitro methods can be used as a part of the biological evaluation of medical devices. |
|
|
 |
| Dr Karla Lienau of Sonova and Dr Rose-Marie Jenvert of SenzaGen presenting the joint poster on the use of GARD® during development of novel materials for intended use in medical devices. |
|
 |
| Guest speaker Dr Christopher Choi presenting the use of GARD® to assess skin sensitizing potency in Takasago’s fragrance ingredient safety program. |
|
|
|
 |
We are very pleased that one of the largest global chemical companies continues to collaborate with us, testing with GARDskin and GARDpotency for hazard and potency assessment of complex mixtures.
Read more about the collaboration |
|
|
|
Together, SenzaGen and VitroScreen provide unique expertise within in vitro toxicology. We are now expanding our services to guide customers through the comprehensive process of biological evaluation of medical devices. Our GLP certified laboratories offer in vitro biocompatibility testing and suggest in vitro strategies for medical device identification and classification. In addition, tailored consultancy services are also provided.
Read more and request a quote |
|
|
|
|
%20Color%20RGB.png)
